WHO ICTRP trial
Efficacy and safety of finelidone in patients with coronary heart disease and…
ChiCTR2500098674 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500098674 |
|---|---|
| Public title | Efficacy and safety of finelidone in patients with coronary heart disease and early renal disease combined with microalbuminuria |
| Scientific title | Efficacy and safety of finelidone in patients with coronary heart disease and early renal disease combined with microalbuminuria |
| Primary sponsor | Sir Run Run Shaw Hospital, Zhejiang University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | coronary heart disease |
| Interventions | Experimental group:In addition to standard treatment for coronary heart disease, finelidone was given: 20mg orally once daily for 16 weeks.;Control group:standard treatment for coronary heart disease, including antiplatelet drugs and… |
| Registration date | Mar 12, 2025 |
| Target size | Experimental group:75;Control group:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: